Investment

© Lonza

Lonza sets up VC fund for North American health and wellness startups

By Adi Menayang

Swiss pharmaceutical and biotech firm Lonza announced a partnership with US-based Prolog Ventures to create a venture capital fund focusing on products that “maintain, protect, or preserve the health and well-being of people and companion animals.”

DSM invests in former patent suit opponent ZeaVision

DSM invests in former patent suit opponent ZeaVision

By Hank Schultz

DSM Venturing, the investment arm of Royal DSM, has announced a strategic investment into ZeaVision, a dietary supplement company based on the benefits of zeaxanthin, a carotenoid eye health ingredient.

Spotlight

Follow us

Featured Events

View more

Products

View more

Webinars

Featured Suppliers

All suppliers